Medullary thyroid carcinoma (MTC) is one of the most challenging cancers.
Epidemiological studies have shown that during the past 30 years neither a change in stage at diagnosis nor a significant improvement in survival has been achieved.
Therefore, new diagnostic and therapeutic strategies are needed for early detection of metastases or disease recurrence and tumor growth control.

Additional Metadata
Persistent URL dx.doi.org/10.20452/pamw.4387, hdl.handle.net/1765/113461
Journal Polskie Archiwum Medycyny Wewnetrznej
Citation
Erba, P, Mäcke, H.R, Mikolajczak, R, Decristoforo, C, Zaletel, K, Maina-Nock, T. (Theodosia), … Hubalewska-Dydejczyk, A. (2017). A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma. Polskie Archiwum Medycyny Wewnetrznej, 128(12). doi:10.20452/pamw.4387